The Brain Endothelin System as Potential Target for Brain-Related Pathologies

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|1|6|543-553

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.6, 2002-12, pp. : 543-553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology and Physiopathology of the Brain Endothelin System: An Overview

By  

Current Medicinal Chemistry, Vol. 13, Iss. 6, 2006-03 ,pp. : 627-638

Bentham Science Publishers

Access to resources Recommend Favorite

Quinoxalines Potential to Target Pathologies

By  

Current Medicinal Chemistry, Vol. 22, Iss. 26, 2015-01 ,pp. : 3075-3108

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Metabolism and Brain Pathologies

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 8, Iss. 3, 2008-09 ,pp. : 187-197

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of the Endocannabinoid System in the Brain

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 609-617

Bentham Science Publishers

Access to resources Recommend Favorite

GLT-1 Upregulation as a Potential Therapeutic Target for Ischemic Brain Injury

By  

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5045-5055

Bentham Science Publishers

Access to resources Recommend Favorite